Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry

This publication has 9 references indexed in Scilit:

• An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan
  Clinical Therapeutics, 1998
• HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats
  Journal of Pharmaceutical and Biomedical Analysis, 1998
• Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Effects of losartan on cerebral and ocular circulation in healthy subjects
  Published by Wiley ,1997
• Clinical safety and tolerability of losartan
  Clinical Therapeutics, 1997
• An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection
  Journal of Pharmaceutical and Biomedical Analysis, 1997
• Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo
  The Japanese Journal of Pharmacology, 1997
• Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular Pharmacotherapy
  The Journal of Clinical Pharmacology, 1993
• Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992